Research programme: antifungals - Thallion Pharmaceuticals

Drug Profile

Research programme: antifungals - Thallion Pharmaceuticals

Alternative Names: Antifungals research programme - Thallion Pharmaceuticals; ECO 02301 class; ECO-02301; ECO-14401; ECO-4401

Latest Information Update: 26 Aug 2009

Price : $50

At a glance

  • Originator Ecopia BioSciences
  • Class Macrolides; Polyenes
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Mycoses

Most Recent Events

  • 26 Aug 2009 No development reported - Preclinical for Mycoses in Canada (unspecified route)
  • 30 Jan 2003 Preclinical trials in Mycoses in Canada (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top